Month: December 2019

Marianne Williamson Is An Anti-Vaxxer

Spouting classic anti-vaccine tropes is no way to prove you are not anti-vaccine.

/ December 11, 2019

Supplements with Multiple Ingredients, Many with No Apparent Rationale

Dietary. supplements frequently have multiple ingredients, often mixtures of vitamins, minerals, and herbs. The rationale for including each ingredient is questionable, to say the least.

/ December 10, 2019
Acupuncture for xerostomia

Spinning a negative acupuncture study: Same as it ever was

Investigators at M.D. Anderson Cancer Center reported the results of a trial of acupuncture for xerostomia (dry mouth) secondary to radiation therapy for head and neck cancers. It was a negative trial, but investigators still tried to spin it as positive, but with a twist. There was a large difference between results found at M.D. Anderson and the second site in China....

/ December 9, 2019

How to make the opioid epidemic worse in Pennsylvania

Two bills are pending in the Pennsylvania legislature - SB 675 aimed at restricting prescription of buprenorphine, and HB 1005 that imposes reporting requirements in cases of suspected drug overdose. Both are a bad idea, and I hope Pennsylvania Governor Tom Wolf will continue his past trends of vetoing bad bills that will harm his constituents.

/ December 6, 2019

Anti-vaxxers try to kill Florida bill ending childhood vaccination religious exemption

Anti-vaxxers and their misinformation campaign may have killed Senate Bill 64, repealing Florida's religious exemption to childhood immunizations, which is being abused by parents. Sen. Laura Book, the bill's sponsor, remains undeterred, citing the high risk of disease outbreaks in Florida.

/ December 5, 2019

Virtual Reality Treatment for PTSD

What does the evidence say about using virtual reality to treat PTSD?

/ December 4, 2019

Alternative Medicine: Placebos for Pets

A skeptical veterinarian reviews the evidence for alternative medicine for pets, and concludes it's mostly placebos.

/ December 3, 2019
One Million Dollars

Would you pay $1 million to enroll in a phase 1 clinical trial of an “anti-aging” gene therapy?

Libella Gene Therapeutics, LLC made the news last week for announcing a "pay-to-play" trial of its telomerase-based anti-aging gene therapy. What was shocking about the announcement was not that it was a "pay-to-play" trial, given that such trials have become all too common, but rather the price of enrollment: $1 million. Worse, the trial is being conducted in Colombia; the therapy doesn't...

/ December 2, 2019